search
Back to results

Ischemia-reperfusion Exercise Study

Primary Purpose

Insulin Sensitivity

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Exercise, insulin infusion
Sponsored by
University of Copenhagen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Insulin Sensitivity focused on measuring Exercise, Glucose Uptake, Ischemia, Insulin Sensitivity

Eligibility Criteria

25 Years - 35 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • normal weight (BMI: below or equal to 27)
  • physical active on a regular basis
  • cardiorespiratory fitness between 40-60 ml/kg/min
  • no history or sign of type 2 diabetes, hypertension, insulin resistance or dyslipidemia

Exclusion Criteria:

  • smoker
  • BMI: above 27
  • using any kind of medication

Sites / Locations

  • Department of Exercise, Nutrition and Sports, Faculty of Sciences, University of Copenhagen

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Low intensity exercise

High intensity exercise

Low intensity exercise + intermittent ischemia-reperfusion

Arm Description

70% of maximal leg work load capacity

70% and 95% of maximal work load capacity (alternately every 5 min)

70% of maximal leg work load capacity with intermittent ischemia (25 seconds every 2 min)

Outcomes

Primary Outcome Measures

Muscle glucose uptake during exercise and enhanced insulin sensitivity in recovery from exercise.
Leg glucose uptake is calculated by the arterial-venous difference i blood glucose concentration multiplied with leg blood flow. Sampling of artery and venous blood samples for blood glucose measurements. Measures of artery blood flow by Ultrasound Doppler technique allows a final calculation of glucose uptake across the legs before exercise, during exercise, in recovery from exercise and with insulin stimulation.

Secondary Outcome Measures

AMPK activity in muscle biopsies
The obtained muscle samples will be subjected to protein kinase activity measurements.
Posttranslational modification of proteins in muscle biopsies
The obtained muscle samples will be subjected to standard western blotting for the evaluation of posttranslational modifications of various proteins involved in glucose metabolism.

Full Information

First Posted
April 29, 2021
Last Updated
January 5, 2022
Sponsor
University of Copenhagen
search

1. Study Identification

Unique Protocol Identification Number
NCT04872426
Brief Title
Ischemia-reperfusion Exercise Study
Official Title
Effect of Ischemia on the Insulin-sensitizing Effect of Exercise
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
August 31, 2018 (Actual)
Primary Completion Date
January 3, 2020 (Actual)
Study Completion Date
January 3, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Copenhagen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The study investigates the relationship between activation of AMP-activated protein kinase (AMPK) in human skeletal muscle and the subsequent improvement in muscle insulin sensitivity for the stimulation of glucose uptake. This will be investigated in young healthy lean male subjects.
Detailed Description
This study aims to demonstrate the association between AMPK activation and increased insulin sensitivity in human skeletal muscle. The investigators intend to examine insulin sensitivity after various levels of AMPK activation in skeletal muscle that includes exercise at different intensities as well as exercise combined with leg blood flow restriction (ischemia). The hypothesis is that exercise combined with ischemia will result in an increased activation of AMPK compared to exercise alone, and therefore it is expected that exercise combined with ischemia will result in the greatest improvement in muscle insulin sensitivity. Methods: The main experiment consists of 3 experimental days (A, B and C), separated by a minimum of 14 days and carried out in a randomised order. On all the study days, the participants will arrive in the laboratory after an overnight fast. Catheters will be placed in both femoral veins and in one femoral artery. A muscle biopsy will be obtained from vastus lateralis of one leg (resting leg). Experiment A consists of one-legged muscle work for 1 hour at 70% of the leg maximum aerobic work capacity with the other leg serving as a resting control. In experiment B, the same work are performed, but with periodic at the same constricting the blood supply to the working leg (25 seconds every 2 min). Experiment C consists of one-legged muscle work for 1 hour at 70% and 95% of the leg maximum aerobic work capacity (alternately every 5 min). Immediately after each type of exercise a biopsy will be obtained from the exercising leg and the participants will rest in the fasted state for 3 hours before a third set of muscle biopsies (from both legs) will be obtained. Subsequently, insulin sensitivity will be evaluated in the participants during a 2-hour physiological hyperinsulinemic euglycemic clamp. By the end of the clamp, a final set of biopsies (both legs) will be obtained. Throughout the study day sampling of artery and venous blood/plasma samples allows for the estimation of substrate extraction by the two legs. Further, measures of artery blood flow by Ultrasound Doppler technique allow for the final calculation of substrate uptake/release across the two legs before exercise, during exercise and in recovery from exercise. Importantly, the ability for insulin to stimulate these processes can be evaluated in both a rested and in a prior exercised leg.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insulin Sensitivity
Keywords
Exercise, Glucose Uptake, Ischemia, Insulin Sensitivity

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Low intensity exercise
Arm Type
Experimental
Arm Description
70% of maximal leg work load capacity
Arm Title
High intensity exercise
Arm Type
Experimental
Arm Description
70% and 95% of maximal work load capacity (alternately every 5 min)
Arm Title
Low intensity exercise + intermittent ischemia-reperfusion
Arm Type
Experimental
Arm Description
70% of maximal leg work load capacity with intermittent ischemia (25 seconds every 2 min)
Intervention Type
Other
Intervention Name(s)
Exercise, insulin infusion
Intervention Description
Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise
Primary Outcome Measure Information:
Title
Muscle glucose uptake during exercise and enhanced insulin sensitivity in recovery from exercise.
Description
Leg glucose uptake is calculated by the arterial-venous difference i blood glucose concentration multiplied with leg blood flow. Sampling of artery and venous blood samples for blood glucose measurements. Measures of artery blood flow by Ultrasound Doppler technique allows a final calculation of glucose uptake across the legs before exercise, during exercise, in recovery from exercise and with insulin stimulation.
Time Frame
Through study completion, an average of 1 year.
Secondary Outcome Measure Information:
Title
AMPK activity in muscle biopsies
Description
The obtained muscle samples will be subjected to protein kinase activity measurements.
Time Frame
5 years
Title
Posttranslational modification of proteins in muscle biopsies
Description
The obtained muscle samples will be subjected to standard western blotting for the evaluation of posttranslational modifications of various proteins involved in glucose metabolism.
Time Frame
5 years

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: normal weight (BMI: below or equal to 27) physical active on a regular basis cardiorespiratory fitness between 40-60 ml/kg/min no history or sign of type 2 diabetes, hypertension, insulin resistance or dyslipidemia Exclusion Criteria: smoker BMI: above 27 using any kind of medication
Facility Information:
Facility Name
Department of Exercise, Nutrition and Sports, Faculty of Sciences, University of Copenhagen
City
København
ZIP/Postal Code
2100
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Ischemia-reperfusion Exercise Study

We'll reach out to this number within 24 hrs